| TO: | Honorable Jane Nelson, Chair, Senate Committee on Health & Human Services |
| FROM: | John S. O'Brien, Director, Legislative Budget Board |
| IN RE: | SB1429 by Van de Putte (Relating to the authority of physicians to delegate to certain pharmacists the implementation and modification of a patient's drug therapy.), Committee Report 1st House, Substituted |
| Fiscal Year | Probable Net Positive/(Negative) Impact to General Revenue Related Funds |
|---|---|
| 2008 | $0 |
| 2009 | $0 |
| 2010 | $0 |
| 2011 | $0 |
| 2012 | $0 |
| Fiscal Year | Probable Savings/(Cost) from GENERAL REVENUE FUND 1 |
Probable Revenue Gain/(Loss) from GENERAL REVENUE FUND 1 |
Change in Number of State Employees from FY 2007 |
|---|---|---|---|
| 2008 | ($53,585) | $53,585 | 1.0 |
| 2009 | ($42,838) | $42,838 | 1.0 |
| 2010 | ($42,838) | $42,838 | 1.0 |
| 2011 | ($42,838) | $42,838 | 1.0 |
| 2012 | ($42,838) | $42,838 | 1.0 |
The bill would amend Occupations Code to provide a physician the authority to delegate to certain pharmacists the implementation and modification of a patient's drug therapy. The bill would require the pharmacist to provide the Board of Pharmacy with a copy of the protocol which provides this delegation, and would require the Board of Pharmacy to provide on its Internet website a list of pharmacists who are authorized to sign a prescription drug order. The bill would require the Board of Pharmacy, with the advice of the Texas Medical Board, to adopt rules that allow a pharmacist to implement or modify a patient's drug therapy pursuant to a physician's delegation.
The bill would take effect September 1, 2007.
It is estimated that Board of Pharmacy would have a cost associated with implementing the provisions of the bill. Based on the analysis of the Board of Pharmacy, it is assumed that 1.0 FTE would be required to review, approve, and enter data of each pharmacist and the pharmacist’s supervising physician under the protocol required.
Based on the analysis of the Board of Pharmacy, it is assumed that costs for staff would be $31,345 for 1.0 FTE in each fiscal year from 2008 through fiscal year 2012. Other operating expenses are estimated at $13,372 in fiscal year 2008 and $2,625 in each fiscal year from 2009 to fiscal year 2012. Estimated costs also include $8,868 in each fiscal year from 2008 through fiscal year 2012 for associated benefits.
This analysis assumes that any increased costs resulting from the bill would be offset by an increase in fee generated revenue.
| Source Agencies: | 503 Texas Medical Board, 515 Board of Pharmacy
|
| LBB Staff: | JOB, CL, MW, AH
|